share_log

8-K: GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company’s Next-Generation COVID-19 Vaccine Candidate, GEO-CM04S1

8-K: GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company’s Next-Generation COVID-19 Vaccine Candidate, GEO-CM04S1

8-K:GeoVax獲得BARDA項目NextGen獎,開展2b期臨床研究,評估該公司的下一代COVID-19候選疫苗GEO-CM04S1
美股SEC公告 ·  06/18 13:18
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息